Background {#Sec1}
==========

Women serving in the United States (U.S.) military are often considered a high-risk population for the acquisition of sexually transmitted infections (STIs). Military demographics contribute to this higher incidence, as younger age, education at the high school (as opposed to college) level, residence in high-prevalence areas and African American race are commonly described as risk factors for STIs, and several of these demographics are overrepresented in the military \[[@CR1]--[@CR3]\]. In addition, a number of sexual risk behaviors, particularly inconsistent condom use or having multiple sexual partners, are highly prevalent among military servicewomen \[[@CR4]--[@CR6]\]. The end result is that STI rates in the military commonly exceed age-matched rates in the general population \[[@CR4], [@CR7]--[@CR10]\].

Increased attention has been given to extragenital reservoirs of gonorrhea (GC) and chlamydia (CT) among heterosexual women. In two U.S. studies of women tested at urban sexually transmitted disease (STD) clinics, the prevalence of anorectal GC/CT ranged between 3.0 and 6.0% and 8.7 and 13.0%, respectively \[[@CR11], [@CR12]\]. Pharyngeal and anorectal GC/CT infections are typically asymptomatic; therefore, exclusive reliance on urogenital testing in high-risk populations has been shown to miss a number of extragenital GC/CT infections \[[@CR11]--[@CR14]\]. Some of these infections may later become symptomatic or facilitate transmission to other individuals who develop more serious infections. Extragenital screening can also promote counseling and awareness that STI transmission is still possible through sexual practices where condoms are less commonly used. Treatment for asymptomatic infections may also differ based on the pathogen and location. For these reasons, extragenital screening of heterosexual women is increasingly advocated, particularly as infections are often detected even without self-reported oral/anal intercourse \[[@CR15], [@CR16]\].

In this pilot study, we sought to examine the prevalence of asymptomatic extragenital GC/CT infection and associated patterns of sexual behavior among young women in the U.S. Navy who are not otherwise identified as at high risk for STIs. A second exploratory objective was to assess the feasibility and acceptance of routine extragenital testing in a primary care setting.

Methods {#Sec2}
=======

Between January and September, 2017, we recruited women between the ages of 18 and 25 who presented to their primary care clinic for an annual exam, as is required of women in the military. We excluded women who were experiencing any symptoms related to GC/CT infection, including urethritis, dyspareunia, pharyngitis and pelvic, abdominal or rectal pain. Prior to clinical examination, the consenting subjects underwent provider-administered endocervical, pharyngeal and rectal swab testing, and the samples were analyzed via nucleic acid amplification testing (Hologic; San Diego, CA). In addition, the women completed an anonymous paper self-administered questionnaire to describe drug/alcohol use and sexual behavior; these surveys were linked to clinical data through use of a single participant identifying number (PIN) without personal identifying information. Self-reported race and ethnicity were also elicited, given the association between STI prevalence and membership of certain demographic groups. All study activities took place at an on-base primary health care clinic in San Diego, California. All patients provided informed consent for the study. The study was approved by the Institutional Review Board of the Uniformed Services University of Health Sciences.

Descriptive statistics were used to compare women with and without a prior history of any STI (self-report) and current GC/CT diagnosis. Nonparametric tests were used to compare medians; Chi-square and Fisher-exact tests were used to compare proportions between groups. Analyses were conducted using SAS software (version 9.3; Cary, NC).

Results {#Sec3}
=======

A total of 75 patients were approached for study participation. Of these, 10 patients were excluded for reporting symptoms consistent with STIs, and 5 opted not to participate, yielding a final sample of 60 women. Demographic characteristics are presented in Table [1](#Tab1){ref-type="table"}. The median age of all participants was 23 years old (interquartile range \[IQR 21, 24\]) and included 20 (33.3%) white, 18 (31.0%) black/African American, 13 (21.7%) Hispanic/Latina and 9 (15.5%) Asian/Pacific Islander women. One-third of the women (*n* = 20) reported a lifetime history of sexual assault.Table 1Demographic characteristics by diagnosis of gonorrhea (GC) or chlamydia (CT), or presence of any prior sexually transmitted infection (STI) by self-reportItemOverall (*n* = 60)Current GC/CT^a^Prior STINo (*n* = 54)Yes (*n* = 6)*P*-valueNo (*n* = 41)Yes (*n* = 19)*P*-valueAge (Median, interquartile range)23 (21,24)23 (21,24)20.5 (19,23)0.02222 (21,24)23 (22,24)0.063Median years of military service (interquartile range)2.7 (1.7,3.9)2.8 (1.8,3.9)1.6 (1.3,2.7)0.1712.6 (1.7,3.9)2.82 (1.6,3.9)0.799Education (*n* (%))0.7380.901 High school diploma or GED26 (43.4)22 (40.7)4 (66.7)18 (43.9)7 (36.8) Some college or Associate degree23 (38.3)21 (38.9)2 (33.3)14 (34.2)9 (47.4) Currently enrolled in college3 (5.0)3 (5.6)0 (0)2 (4.9)1 (5.3) 4-year college degree8 (13.3)8 (14.8)0 (0)6 (14.6)2 (10.5)Race/Ethnicity (*n* (%))0.8400.875 White20 (33.3)17 (31.5)3 (50.0)15 (36.6)5 (26.3) Black/African American18 (31.0)16 (29.6)2 (33.3)12 (29.3)6 (31.6) Hispanic/Latino13 (21.7)12 (22.2)1 (16.7)8 (19.5)5 (26.3) Asian/Pacific islander9 (15.5)9 (16.7)0 (0)6 (14.6)3 (15.8)Rank (*n* (%))0.4360.648 Enlisted55 (91.7)49 (90.7)6 (100)38 (92.7)17 (89.5) Officer5 (8.3)5 (9.3)0 (0)3 (7.3)2 (10.5)Current marital status (*n* (%))0.8250.182 Never married37 (61.7)32 (59.3)5 (83.3)26 (63.5)11 (57.9) Married/Life partner17 (28.3)16 (29.6)1 (16.7)13 (31.7)4 (21.0) Married/Life partner (separated)4 (6.7)4 (7.4)0 (0)1 (2.4)3 (15.8) Divorced2 (3.3)2 (3.7)0 (0)1 (2.4)1 (5.3)Victim of sexual assault, ever (*n* (%))0.3250.466 No35 (58.3)31 (59.6)4 (66.7)22 (53.7)13 (68.4) Yes20 (33.3)19 (36.5)1 (16.7)15 (36.6)5 (26.3) Prefer not to answer3 (5.0)2 (3.9)1 (16.7)3 (7.3)0 (0)Time deployed (*n* (%))0.6630.400 None35 (58.3)31 (57.4)4 (66.7)22 (53.7)13 (68.4) 1--2 times25 (41.7)23 (42.6)2 (33.3)19 (46.4)6 (31.6)Last deployed (*n* (%))0.6080.5812 Within the past 12 months6 (20.7)6 (23.1)0 (0)5 (23.8)1 (12.5) 12 and 24 months ago14 (48.3)12 (46.1)2 (66.7)11 (42.4)3 (37.5) 24^+^ months ago5 (17.2)5 (19.2)0 (0)3 (14.3)2 (25.0) Prefer not to answer4 (13.8)3 (11.5)1 (33.3)2 (9.5)2 (25.0)Missing values are not included in the table. ^a^All infections were CT. *GED* General educational development. *P*-values derived from the Kruskal-Wallis test for continuous variables and the chi-squared or Fisher exact test with Monte Carlo estimation for categorical variables

With respect to sexual behavior (Table [2](#Tab2){ref-type="table"}), 58 (96.7%) reported being sexually active over the prior year and had a regular sexual partner, and 30 (50.0%) reported two or more partners in the last 6 months. In addition, 23 (38.3%) of the women reported having had a casual sexual partner over the last 6 months; of the women who reported sex with a casual partner at any point in time, 19 of 45 (42.2%) reported that they rarely or never use condoms. With respect to alcohol use, 25 (41.7%) of all the women reported consuming at least 3 drinks on a typical drinking day, and 20 (33.3%) reported drinking more than once per week. When asked about their most recent sexual encounter, 56 (93.3%) of the women reported vaginal sex with a male partner while 57 (95.0%) and 15 (25.0%) of women reported oral and anal sex, respectively. Most anal intercourse 86.7% (13/15) was condomless in these encounters.Table 2General sexual and alcohol-related risk behaviors by prior sexually transmitted infection (STI) (n (%))ItemOverall (*n* = 60)Current or prior STINo (*n* = 37)Yes (*n* = 23)*P*-value^a^Vaginal sex with male partner0.978 Never1 (1.7)1 (2.7)0 (0) One time or a few times a year9 (15.0)5 (13.5)4 (17.4) Monthly6 (10.0)3 (8.1)3 (13.0) Once a week6 (10.0)4 (10.8)2 (8.7) A few times a week35 (58.3)22 (59.5)13 (56.5) Daily2 (3.3)1 (2.7)1 (4.4) Prefer not to answer1 (1.7)1 (2.7)0 (0)Condom use during vaginal sex0.195 Never30 (50.0)15 (40.6)15 (65.2) Rarely8 (13.3)6 (16.2)2 (8.8) Sometimes8 (13.3)5 (13.5)3 (13.0) Usually8 (13.3)5 (13.5)3 (13.0) Always6 (10.0)6 (16.2)0 (0)Anal sex0.284 Never41 (68.3)25 (67.6)16 (69.6) One time or a few times a year17 (28.3)12 (32.4)5 (21.7) Monthly1 (1.7)0 (0)1 (4.4) A few times a week1 (1.7)0 (0)1 (4.4)Condom anal sex0.931 Never19 (63.3)12 (57.1)7 (77.8) Rarely3 (10.0)2 (9.5)1 (1.1) Sometimes2 (6.7)2 (9.5)0 (0) Usually1 (3.3)1 (4.8)0 (0) Always3 (10.0)2 (9.5)1 (1.1) Prefer not to answer2 (6.7)2 (9.5)0 (0)Contraception use0.571 No18 (30.0)10 (27.0)8 (34.8) Yes42 (70.0)27 (73.0)15 (65.2)Have main sexual partner0.730 No2 (3.3)1 (2.7)1 (4.3) Yes58 (96.7)36 (97.3)22 (95.7)Gender of main partner0.581 Male54 (90.0)33 (89.2)21 (91.3) Female4 (6.7)3 (8.1)1 (4.3)Main partner, active duty military0.243 No16 (26.7)12 (32.4)4 (17.4) Yes42 (70.0)24 (64.9)18 (78.3)Sexual partners last 6 months0.471 None9 (15.0)5 (13.5)4 (17.4) One12 (20.0)8 (21.6)4 (17.4) 2--427 (45.0)15 (40.5)12 (52.2) 5--83 (5.0)3 (8.1)0 (0) Prefer not to answer1 (1.7)1 (2.7)0 (0)Casual number of sexual partners0.791 None28 (53.9)18 (48.7)10 (43.5) Some5 (9.6)3 (8.1)2 (8.7) Half5 (9.6)2 (5.4)3 (13.0) Most5 (9.6)4 (10.8)1 (4.3) All8 (15.4)6 (16.2)2 (8.7) Prefer not to answer1 (1.9)1 (2.7)0 (0)Frequency of condom use with casual male partner0.699 Never16 (32.0)9 (24.3)7 (30.4) Rarely3 (6.0)2 (5.4)1 (4.3) Sometimes5 (10.0)2 (5.4)3 (13.0) Usually5 (10.0)4 (10.8)1 (4.3) Always16 (32.0)12 (32.4)4 (17.4) Prefer not to answer5 (10.0)3 (8.1)2 (8.7)Frequency of alcohol consumption, last 6 months0.157 4 or more times a week2 (3.4)0 (0)2 (8.7) 2--3 times a week18 (30.5)11 (29.7)7 (30.4) 2--4 times a month18 (30.5)12 (32.4)6 (26.1) Once a month or less15 (25.4)9 (24.3)6 (26.1) I did not drink alcohol in the past year4 (6.8)4 (10.8)0 (0) I have never drunk any alcohol in my life1 (1.7)0 (0)1 (4.4) Prefer not to answer1 (1.7)0 (0)1 (4.4)Alcohol drinks typical day, last 6 months0.929 10 or more drinks3 (5.2)2 (5.7)1 (4.4) 7--9 drinks1 (1.72)0 (0)1 (4.4) 5--6 drinks5 (8.62)3 (8.6)2 (8.7) 3--4 drinks16 (27.59)9 (25.7)7 (30.4) 1--2 drinks27 (46.55)17 (48.6)10 (43.5) Prefer not to answer6 (10.34)4 (11.4)2 (8.7)Sex after alcohol0.602 Never13 (21.7)9 (24.3)4 (17.4) Rarely19 (31.7)11 (29.7)8 (34.8) Sometimes18 (30.0)12 (32.4)6 (26.1) Often6 (10.0)4 (10.8)2 (8.7) Every time2 (3.3)0 (0)2 (8.7) Prefer not to answer2 (3.3)1 (2.7)1 (4.4)Last sexual encounter Engaged in vaginal sex--  No4 (6.7)3 (8.1)0 (0)  Yes56 (93.3)34 (91.9)23 (100) Performed oral sex on partner--  No1 (1.7)1 (2.7)0 (0)  Yes57 (95.0)34 (91.9)23 (100) Engaged in anal sex0.873  No45 (75.0)31 (75.6)14 (73.7)  Yes15 (25.0)10 (24.4)5 (26.3) Used condoms^b^--  No13 (86.7)7 (77.8)6 (100)  Yes2 (13.3)2 (22.2)0 (0.0)Missing values are not included in the table. ^a^*P*-values derived from Kruskal-Wallis test for continuous variables, and chi-squared or Fisher exact test with Monte Carlo estimation for categorical variables; ^b^*n* = 15 overall, *n* = 9 for women with no history of STI, *n* = 6 for women with current/prior STI

Six women (10.0%) were diagnosed with current chlamydia infection, all via endocervical exam, including one case without extragenital infection. Concurrent anorectal infection was noted among five women (8.3%), including two cases accompanied by pharyngeal infection (3.3%). Pharyngeal infection without genital infection was not observed.

Discussion {#Sec4}
==========

We found a high prevalence of chlamydia among military servicewomen, particularly among those with a prior history of an STI, consistent with the findings of larger studies \[[@CR2], [@CR3]\]. Neither pharyngeal nor rectal GC/CT were observed without endocervical infection, although five of six infections involved extragenital sites. The common practices of oral and anal intercourse, as reported by study participants, demonstrate a clear, ongoing risk for extragenital GC/CT infection.

Our lack of additional case-finding via extragenital screening differs from several large studies. A review of 4402 women reporting extragenital exposures at two Baltimore STD clinics found that urogenital-only testing would have missed 30.3% of GC and 13.8% of CT infections \[[@CR12]\]. In the United Kingdom, an audit of GC/CT screening at an STD clinic found that 11% of pharyngeal CT cases (7/62) and 29% (2/7) would have otherwise been undiagnosed without extragenital testing \[[@CR13]\]. It is likely that our small sample size contributed to this difference, along with the inherent differences between individuals seeking care at a primary care versus STD clinics.

Given the high concordance of anorectal and urogenital CT infection, it seems likely that a larger sample may have uncovered cases of exclusive anorectal infection, even as we did find a high proportion of concurrent infection. Likewise, in their retrospective review of STD clinic visits in Columbus, Ohio, Bazan et al \[[@CR11]\] found that rates of anorectal and urogenital GC/CT were similar, and 19% of the women had anorectal infection alone. Findings such as these have directed many programs toward broader screening. For instance, a review of STI clinic records in Amsterdam found no significant difference in the prevalence of anorectal CT among 192 women (10.4%) who underwent universal screening compared with 4405 women who underwent selective testing (9.5%). As a result, the authors argue that universal screening should be favored in light of the notion that many women may not automatically identify as being at-risk for extragenital GC/CT infection \[[@CR14]\]. At non-STI clinics such as ours, a patient-directed approach may nonetheless be reasonable.

To our knowledge, this is the first description of patterns of anal intercourse among military women. Nearly one-third of the women reported anal intercourse within the past year, and most of these encounters were condomless. Significant overlap was also observed in the type of sex reported at the last sexual encounter, as has been observed in other studies \[[@CR17]\]. Of course, subjects may have opted for extragenital testing based on their perceived risk, and the true extent of this sexual practice may be lower; nevertheless, considerable risk is already evident from these data alone. Thus, education and interventions to decrease the incidence of STIs should also emphasize the potential for anorectal STIs, along with the increased risk for human immunodeficiency virus (HIV) acquisition from localized tissue trauma during condomless anal intercourse.

Our behavioral questionnaire also elucidated a high volume and frequency of alcohol consumption, with 41.7% of the women consuming three or more drinks on a typical drinking day. These findings are consistent with other reports of alcohol-related risk among military women. In a study of 3083 active-duty personnel, 38% reported binge drinking (\> 4 drinks) over the last 30 days \[[@CR18]\]. O'Rourke et al \[[@CR5]\] found a similar prevalence of binge drinking (33%) and found that it was associated with a decreased likelihood of contraception use, including condoms. We did not obtain detailed histories on situational alcohol use, but prior research among Navy servicewomen has found that they may use binge drinking as a way to fit in with male counterparts, which can leave them vulnerable to unwanted sexual encounters \[[@CR19]\].

Although not associated with GC/CT infection, the high prevalence of lifetime sexual assault in our study (33.3%) is noteworthy. The most recent Department of Defense annual report on sexual assault found a 10% increase in the number of reported assaults between 2016 and 2017, though related surveys have found an actual decrease between 2012 and 2016 of 43% \[[@CR20]\]. We did not ask whether the assault occurred in or outside the military; nevertheless, these data have implications for the physical health, psychological well-being, and STI exposure of women. For instance, one study found an association between sexual assault and cytologic abnormalities among 999 female veterans, 62% of whom reported a lifetime history of sexual assault \[[@CR21]\]. Screening for sexual assault in clinical care encounters and research studies of women's health is therefore warranted.

This study had several limitations. As a cross-sectional study, causal inferences cannot be inferred. All questionnaire-related data were collected by self-report and may have been subject to social desirability bias. The survey, however, was anonymous and self-administered, and thus these effects were likely minimal. In any event, we report a high prevalence of socially undesirable behaviors (e.g., condomless anal intercourse), which should have biased data in the opposite direction. Finally, as noted above, our small sample size permitted a more robust comparison of trends associated with extragenital GC/CT infections.

When part of routine care, we found that extragenital STI testing was widely accepted by women, as evidenced by the rate of recruitment into our study. Providers in our study required only minimal training for the performance of pharyngeal and rectal swabs, which themselves are increasingly self-performed \[[@CR22]\]. While recommendations for STI screening in routine primary care are designed for use in the general population, our findings suggest that military women may have increased risk for STIs, and screening criteria may need to be more inclusive. The widespread exposures and significant extent of anorectal infection may provide justification for wider adoption and study of extragenital GC/CT testing among women in the U.S. military.

Conclusions {#Sec5}
===========

We found a high prevalence of chlamydia in our sample of active-duty women in the U.S. Navy, and while neither pharyngeal nor rectal infections were observed without endocervical infection, five of the six diagnosed cases involved extragenital sites. The high prevalence of condomless anal intercourse reported by participants indicates a need for further study and ongoing consideration of extragenital GC/CT screening among high-risk patients. Behavioral interventions are also warranted given the high prevalence of sexual and related risk factors.
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